| Literature DB >> 35409420 |
Audrey Grossen1, Kyle Smith1, Nangorgo Coulibaly1, Benjamin Arbuckle1, Alexander Evans1, Stefan Wilhelm2,3,4, Kenneth Jones5, Ian Dunn1, Rheal Towner1,3, Dee Wu6, Young-Tae Kim7,8, James Battiste1,3.
Abstract
The invasive capabilities of glioblastoma (GBM) define the cancer's aggressiveness, treatment resistance, and overall mortality. The tumor microenvironment influences the molecular behavior of cells, both epigenetically and genetically. Current forces being studied include properties of the extracellular matrix (ECM), such as stiffness and "sensing" capabilities. There is currently limited data on the physical forces in GBM-both relating to how they influence their environment and how their environment influences them. This review outlines the advances that have been made in the field. It is our hope that further investigation of the physical forces involved in GBM will highlight new therapeutic options and increase patient survival. A search of the PubMed database was conducted through to 23 March 2022 with the following search terms: (glioblastoma) AND (physical forces OR pressure OR shear forces OR compression OR tension OR torsion) AND (migration OR invasion). Our review yielded 11 external/applied/mechanical forces and 2 tumor microenvironment (TME) forces that affect the ability of GBM to locally migrate and invade. Both external forces and forces within the tumor microenvironment have been implicated in GBM migration, invasion, and treatment resistance. We endorse further research in this area to target the physical forces affecting the migration and invasion of GBM.Entities:
Keywords: chemoresistance; glioblastoma; physical forces; tumor microenvironment
Mesh:
Year: 2022 PMID: 35409420 PMCID: PMC9000211 DOI: 10.3390/ijms23074055
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Identification of Studies via PRISMA Guidelines.
External/Applied/Mechanic Forces in GBM.
|
|
|
|
| |
|---|---|---|---|---|
|
| Chen et al. [ | Piezo/PIEZO1 | Drosophilia glioma model in vivo; mice xenograft experiments; RNA sequencing of two human GBM stem cell lines (G508 and G532) | Regulator of mitosis and tissue stiffness through activation of integrin-FAK signaling; correlated with GBM aggressiveness and decreased survival |
| Miroshnikova et al. [ | Tenascin C | Patient-derived samples; mouse model | ECM stiffness represses miR-203 expression which activates HIF1α-dependent TNC deposition, which may induce aggressiveness and lead to recurrence | |
| Sen et al. [ | Talin-1 | U373 MG human glioma cells | Involved in mechanical rigidity sensing; transmits signals from the ECM to the cytoskeleton through interplay of integrins and actin | |
| Khan et al. [ | N/A | CD 133+ GBM cells | Actively migrating GBMs exhibit higher elastic stiffness at the front end, facilitating traction needed for forward movement through an anchoring effect | |
|
| Barnes et al. [ | Tension (tenescin) | Patient-derived samples; mouse model | Tension-mediated glycocalyx–integrin feedback loop which promotes mesenchymal characteritistics |
| Shen et al. [ | Yes-associated protein (YAP) | G55 GBM cells | Re-localization of YAP to the cell nucleus indicates a higher degree of cytoskeletal tension during migration of GBM cells in a physically confined environment | |
|
| de Semir et al. [ | Pleckstrin homology domain-interacting protein (PHIP) | In vitro and in vivo murine model of U-251 GBM cell lines | Plays a role in activating the actin cytoskeleton, focal adhesion dynamics, migration, and invasion |
| Gordon et al. [ | Latex beads displacement and cell line volumetric growth | In vitro using human U87MGmEGFR | Demonstrated that tumor cells will grow towards the path of least resistance through traction-mediated forces | |
|
| Agosti et al. [ | N/A | U87 GBM cell lines | During proliferation, GBM aggregation is enabled when the adhesive force between cells is of the same magnitude of the drag forces of cells as they expand |
|
| Voutouri et al. [ | Vessel option | Mathematical model | Compression led to hypoxia and resultant angiogenesis |
| Calhoun et al. [ | miR548 family | LN229 and U251 GBM cell lines; pathway analysis | Increased migration and decreased proliferation, characteristics associated with tumor aggressiveness | |
| Demou et al. [ | Caveolin-1, integrin-β1, Rac1 | U87 and HGL21 GBM cells | Cell deformation/compression leads to downregulation of E-cadherin (CDH1) and PECAM-1 (CD31) and overexpression of PTEN and Rac1; resultant decrease in cell adhesion and increased migration | |
|
| Morjen et al. [ | Kunitz-typeprotease inhibitor (PIVL) | In vitro using U87 cell lines; in vivo mouse model | Disrupted GBM migration, invasion, and adhesion through inhibition of integrin |
| Yao et al. [ | P311/PTZ17 | In vivo mouse model | Rho GTPase-mediated promotion of migration of epidermal stem cells | |
|
| Claus et al. [ | N/A | Case report | Increased CSF protein concentration caused increased ICP and patient deterioration |
| Takara et al. [ | N/A | Case report | Increased CSF protein concentration led to hydrostatic pressure build up | |
| Zoi et al. | Polycystin-1 (PC1) | T98G GBM cells subjected to coninuous hydrostatic pressure and/or PC1 blockade | Hydrostatic pressure inhibited proliferation and migration of GBM cells. PC1 had the opposite effect | |
|
| Perez et al. [ | N/A | (U87) tumor spheroid aggregation methodology based on magnetic cell labeling; spheroid cell invasion w/ Matrigel | Magnetic properties of the spheroids allow for determination of surface tension |
| Chen et al. [ | Hexagonal superparamagnetic cones | U-343 GBM cell lines | Magnetic field gradient | |
|
| Catacuzzeno et al. [ | Swelling-activated chloride currents | In vitro using GL-15 GBM cells | Channel activation included shape and volume changes, allowing migration and invasion |
| Pu et al. [ | Caveolin-1, CAVIN1; uPA and MMPs; AQP1 | U87, U118, and U251 GBM cell lines | Play a role in the response to increased pressure and GBM invasion | |
| Pu et al. [ | Snail-1, Snail-2, N-cadherin, Twist, and vimentin | GBM cell lines U87 and U251; patient-derived neural oncospheres | EMT and invasion through production of matrix proteases as a response to osmotic/hydrostatic pressure | |
|
| Rezk et al. [ | Nestin and vimentin; actin filaments, vinculin, paxillin, and FAK | Patient-derived samples | Increased migration and proliferation |
|
| Ciarletta et al. [ | N/A | Theoretical calculation of buckling instability from solid stresses | Residual stresses promote buckling instability and promote tumor invasion |
| Stylianopoulos et al. [ | Collagen, hyaluronan | Mathematical model | Increased perfusion of tumors led to improved oxygenation and drug delivery |
N/A: Not applicable.
Tumor Microenvironment Forces in GBM.
|
|
|
|
| |
|---|---|---|---|---|
|
| Fischer et al. [ | HAMLET | In vitro using non-transformed human astrocytes CC-2565; in vivo animal models using human GBM xenografted rat models | HAMLET selectively induced GBM apoptosis in rat xenograft models via activation of programmed cell death. HAMLET did not interact with healthy tissue and extended survival by relieving GBM pressure symptoms via volume reduction |
| Sforna et al. [ | Swelling-activated chloride currents | In vitro using GL-15, U87MG, and U251 cells lines | Acute and cyclic hypoxic conditions (either blood flow interuptions) may enable GBM cells to upregulate I(Cl,swell) conditions, which regulate the cellular volume and prevent cellular death | |
|
| Chida et al. [ | N/A | Case report | Increased high CSF protein and pressure hypothesized to cause aggressive phenogype |
| Rifikinson-Mann et al. [ | N/A | Case series of hydrocephalus associated with intramedullary spinal GBM | Malignant tumors were associated with tumor extension and ventriculomegaly | |
| Yoo et al. [ | Hyaluronic acid | U87MG, U373MG, and U251MG glioma cells; transwell assay | In response to radiation, HA production was increased in GBM cells by HA synthase-2 (HAS2), which was transcriptionally upregulated by NF-ĸB. Notably, NF-ĸB was persistently activated by an IL-1α-feedback loop, making HA abundant in tumor microenvironment after radiation |
N/A: Not applicable.
Figure 2Tensile Force in GBM. Tension vector (white arrow) applied to GBM cell exerts force on the GBM cell membrane, and in response, the GBM produces an extracellular glycocalyx matrix (purple curved arrow) leading to matrix growth (purple straight arrow); the glycocalyx matrix can pull on the surrounding healthy tissue, inducing net tensile force at the leading borders of the GBM (red arrow).
Figure 3Compressive Force in GBM. The external environment will exert compressive forces on the GBM cell (white arrow vectors). When GBM grows in a fixed volume or is surrounded by immobile tissue (black arrows), it will also exert compressive forces on the surrounding tissue structure (red arrows).
Figure 4Adhesive, Traction, and Drag Forces in GBM. GBM upregulates various surface proteins, enabling it to adhere to the surfaces of healthy tissue; the increased adherence also helps GBM to resist the physical forces of other tissues or fluids via increased traction forces directly at the surface interface and drag forces at the free margins of the cancer.
Figure 5Hydrostatic and Osmotic Pressure in GBM. As GBM grows and produces excess proteins (black cellular arrows and yellow margins) in the fixed craniospinal volume, both hydrostatic and osmotic pressures (black arrows at edges) will build as the intercranial fluid and extracellular protein concentrations continue to increase.
Figure 6Intracranial Pressure in GBM. As the tumor grows rapidly inside the brain, the overall size of the brain increases and causes tissue to start pressing against the cranium. As a result, the cranium exerts compressive forces back on the brain that result in an increase in intracranial pressure.
Figure 7Cellular Volume in GBM. GBM cells express an abundance of chloride ion channels. Along with aquaporin channels and various ATPases, those channels allow the cells to shrink or swell depending on the environment to aid in the survival of GBM cells.
Figure 8Adhesion and Genetic Mutation in GBM. Cellular membrane proteins play a role in individual GBM cell adhesion to the core tumor. However, through genetic mutation, GBM cells can induce an overexpression of hyaluronic acid, which serves as a ligand for CD-44 receptors. The CD-44 receptors activate SRC complexes that induces a shift to mesenchymal shift in GBM.